Diagnosing NTM and Bronchiectasis: Best Practices for Early and Accurate Recognition

Early recognition and diagnosis of nontuberculosis mycobacteria (NTM) and bronchiectasis are key for optimal patient management. However, these conditions are often misdiagnosed as COPD or asthma, leading to significant challenges and delays in treatment. Join Nathan Falk, MD, MBA, and Ashwin Basavaraj, MD, FCCP, as they share perspectives on accurately diagnosing NTM and bronchiectasis with early symptom recognition, a thorough patient history, and testing.

This episode is part of CHEST’s Bridging Specialties®: Timely Diagnosis for NTM Disease and Bronchiectasis program.

This program is produced in partnership with CHEST and is sponsored by Insmed Incorporated.